Learn more

ILDONG PHARM CO LTD

Overview
  • Total Patents
    109
  • GoodIP Patent Rank
    40,448
  • Filing trend
    ⇩ 100.0%
About

ILDONG PHARM CO LTD has a total of 109 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1996. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CUI KUNYUAN, LORUS THERAPEUTICS INC and JANSSEN SCIENCES IRELAND UNLIMITED CO.

Patent filings per year

Chart showing ILDONG PHARM CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kang Jae Hoon 67
#2 Kang Jae-Hoon 32
#3 Yeon Seung Woo 17
#4 Kwon Hyuk Sang 16
#5 Kang Dae Jung 15
#6 Ryu Jung Su 12
#7 Kang Dae-Jung 12
#8 Yoo Jong Su 11
#9 Kim Seong Beom 11
#10 Lee Hong Sub 10

Latest patents

Publication Filing date Title
WO2016178493A1 Tyndallized clostridium butyricum having effect of preventing and treating arthritis, and use thereof
MX2017012506A Pharmaceutical composition for preventing and treating eye diseases, containing, as active ingredient, fusion protein in which tissue-penetrating peptide and anti-vascular endothelial growth factor preparation are fused.
KR20160034280A Microencapsulation of spore-forming probiotics removed an autolysin and spore-forming probiotics prepared thereby
KR101635724B1 An improved process for the preparation of gefitinib
KR20150005486A Method of preparing functional fermented turmeric gel having anti-oxidant, moisturizing and anti-biotic effect using a probiotic lactic acid bacteria and functional fermented turmeric gel prepared thereby
KR20160050325A Novel solvated crystalline of Raloxifene hydrochloride and process for preparing Raloxifene hydrochloride monohydrate
KR20150031196A A novel phtalazinone derivatives and manufacturing process thereof
KR20160024599A Cold and warmth water purifier having closed type water storage tank
KR20160014881A A novel process for crosslinked hyaluronic acid derivatives
WO2015009052A1 Fusion protein of immunoglobulin hybrid fc and enzyme
KR20150137272A Pregabalin sustained release tablet formulation and process
KR20150127436A Macromolecular polysaccharide binder conjugated Lactobacillus rhamnosus RHT-3201, and use thereof in prevention and treatment of atopic dermatitis
KR20150083255A Multicoating pharmaceutical composition containing duloxetin
KR20150064857A HIF-1α INHIBITOR FOR TREATING THE DESEASE CONCERNING ANGIOGENESIS
KR20150027469A Antiviral composition showing effects on NK cell activation
KR20140130599A Composition for preventing or treating neuropathic pain comprising extract of Melia toosendan
KR20140115149A Method for manufacturing of hyaluronic acid and the composition for anti adhesion comprising the hyaluronic acid by the same method
KR20140052306A New peptide deformylase inhibitor compounds and the manufacturing process thereof
KR20140028820A Novel peptide deformylase inhibitor compounds and a method for producing the same
KR20130018548A Novel prodrugs of 5-(2,4-dihydroxy-5-isopropylphenyl)-n-ethyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide